More than 16,000 patients have filed a Yaz lawsuit so far for injuries based on the failure of Bayer to warn of the risks. Now, the company has started settling many cases with those who suffered blood clot-related injuries such as DVT, pulmonary embolism or stroke.
Yaz and Yasmin became widely used after heavy marketing by Bayer showing them as birth control alternatives that promised safety with limited PMS, bloating, and acne, compared to traditional oral contraceptives. An estimated 100 million women have been prescribed the drugs.
Yaz Lawsuits in Southern District of Illinois
Today, Yaz is still among the most widely used birth control drugs in the United States. In recent years, however, the FDA, Institute for Safe Medication Practices, British Medical Journal, New England Journal of Medicine and other experts have warned that Yaz and Yasmin may be linked to blood clots.
Based on Bayer’s most recent financial records update, they have already spent around $1.75 billion to settle nearly 9,000 claims. More funds have been reserved for those affected, however, victims must still file a Yaz lawsuit to take part in the settlement, and time is limited.
If you suffered a blood clot, DVT, pulmonary embolism or stroke after taking Yaz, it is important to speak with a lawyer as soon as possible to find out how to be included in the current Yaz settlement. Contact us today to speak with a lawyer.
Due to the number of patients filing a Yaz lawsuit, the cases were consolidated to a special federal Multi-District Litigation court in Illinois. This differs from a class action lawsuit in that claims are still handled individually, which can result in higher awards. Also, victims are free to choose their own legal counsel.
Bayer chose to settle the growing claims after a wave of repeated publications linking Yaz and Yasmin to blood clots.
In 2011, the British Medical Journal and FDA both warned that combined hormone drugs which contain drospirenone, such as Yaz and Yasmin, may substantially increase the risk of blood clots.
The Institute for Safe Medicine Practices reported in May of 2012 that Yaz and Yasmin ranked second highest in 2011 for the number of complications reported to the FDA. So far, the agency has received over 16,000 adverse reports related to Yaz or Yasmin just for DVT or pulmonary embolism.
Blood clots can cause serious or life-threatening conditions like stroke, deep vein thrombosis (DVT), or pulmonary embolism.
Those who have suffered lost wages, medical bills, hospitalization, ongoing treatment or pain and suffering from blood clots can get help with the proceeds of a Yaz lawsuit. Lawyers are still helping those affected file claims, however, recent news indicates the litigation could end this year.
If you have been treated for a blood clot injury such as DVT, pulmonary embolism or stroke after taking Yaz, it is important to find out whether you can be included in the settlement, how to proceed and how long you have to take action.
Bayer has indicated they are only settling lawsuits involving blood clot injuries and only certain cases may qualify. A lawyer can discuss your situation today.
Due to the complex and specialized nature of federal defective drug litigation, it is important to find a lawyer or law firm with experience fighting large drug companies.
The DrugNews Center only recommends lawyers who specialize in defective drug cases and have already settled numerous Yaz lawsuits.
For more information on the side effects or legal action involving Yaz, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.